Last reviewed · How we verify

NCT05130216

Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty

Completed Last updated 9 January 2026
What this trial tests

trial testing Genicular Nerve Radiofrequency Ablation in Total Knee Arthroplasty in 5 participants. Completed in 1 October 2025.

Timeline
22 September 2021
Primary endpoint
1 October 2025
1 October 2025

Quick facts

Lead sponsorUniversity of Utah
StatusCompleted
Study typeOBSERVATIONAL
Enrollment5
Start date22 September 2021
Primary completion1 October 2025
Estimated completion1 October 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Utah

Who can join

Adults 30 to 90, any sex, with Total Knee Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determine if genicular nerve radiofrequency ablation (RFA) is a clinically effective intervention for patients with chronic knee pain post-total knee arthroplasty (TKA) as defined by pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Total Knee Arthroplasty

Currently open trials in the same condition.

Other University of Utah trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05130216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing